Cargando…
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
BACKGROUND/AIMS: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, adrenal hyperactivity and decreased mental health. We aimed to investigate the changes in adrenal activity, metabolic status and mental health in PCOS during treatment with escitalopram or placebo. METHODS: Fort...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861369/ https://www.ncbi.nlm.nih.gov/pubmed/29472241 http://dx.doi.org/10.1530/EC-18-0077 |